Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer.
Saved in:
| Title: | Efficacy of CLDN18.2-Targeted Radiotheranostics in Patient-Derived Models of Gastric Cancer. |
|---|---|
| Authors: | Klauser PC; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Dehlavi G; Department of Chemistry, Hunter College, City University of New York, New York, New York.; Graduate Center of City University of New York, New York, New York., De Franco M; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Loor A; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Viray T; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Michel A; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York., Qeriqi B; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York., de Stanchina E; Antitumor Assessment Core Facility, Memorial Sloan Kettering Cancer Center, New York, New York., Carter LM; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York., Carrasco SE; Laboratory of Comparative Pathology, Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center, and Rockefeller University, New York, New York., Zeglis BM; Department of Chemistry, Hunter College, City University of New York, New York, New York.; Graduate Center of City University of New York, New York, New York., Janjigian YY; Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York; and., Lewis JS; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York; lewisj2@mskcc.org.; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pharmacology, Weill Cornell Medical College, New York, New York. |
| Source: | Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 May 01; Vol. 67 (5), pp. 765-772. Date of Electronic Publication: 2026 May 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1535-5667 |
|---|---|
| DOI: | 10.2967/jnumed.125.271098 |
